Please login to the form below

Not currently logged in
Email:
Password:

Fluarix Quadrivalent

This page shows the latest Fluarix Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

GSK gets OK for second quadrivalent flu vaccine in US

GSK gets OK for second quadrivalent flu vaccine in US

GSK joined the club when its Fluarix Quadrivalent was approved by the FDA last December, and since then Sanofi has also been given a green light for its Fluzone Quadrivalent, giving ... This year the WHO also made recommendations for quadrivalent

Latest news

  • FDA approves Sanofi's four-in-one flu vaccine FDA approves Sanofi's four-in-one flu vaccine

    It becomes the third major four-strain influenza vaccine approved in the US following FDA backing for AstraZeneca's FluMist Quadrivalent in March 2012 and GlaxoSmithKline's (GSK) Fluarix Quadrivalent nine ... which is approved in people aged two to 49,

  • GSK’s four-strain flu vaccine approved in Germany and UK GSK’s four-strain flu vaccine approved in Germany and UK

    Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK. ... GSK launched its four-strain version in the US last December under the Fluarix Quadrivalent name, and with AstraZeneca/Medimmune's FluMist Quadrivalent already on the market,

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics